Products 35700-27-7

CAS 35700-27-7 appears in our catalog under these names: 15(S)-15-methyl Prostaglandin E2, 15(S)–15–methyl Prostaglandin E2, (15S)-15-Methylprostaglandin E2. Offered by: TargetMol, GLPBio, MedChemExpress. Available pack sizes: 1mg, 500ug, 500μg, 1 mg.

15(S)-15-methyl Prostaglandin E2
TargetMol
  • size: 1mg, 500ug
  • Variants: 2
from 1555.02
View product
15(S)–15–methyl Prostaglandin E2
GLPBio
  • size: 1mg, 500μg
  • Variants: 2
from 962.12
View product
(15S)-15-Methylprostaglandin E2
MedChemExpress
  • size: 1 mg
  • Variants: 1
from 1819.70
View product
Structural formula: {0} (CAS {1})

15-Methyl-15S-PGE2 is a prostanoid.

Source: ChEBI

Identity
Molecular formulaC21H34O5
Molecular weight366.5 g/mol
IUPAC name(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
InChIKeyXSGQFHNPNWBVPT-DSFPJDRCSA-N
SMILESCCCCC[C@@](C)(/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O

Computed by PubChem (NCBI)

Synonyms: 15-methyl-15S-PGE2, 15(S)-15-methyl Prostaglandin E2, (15S)-15-Methylprostaglandin E2, 15-methyl-15S-Prostaglandin E2, 9-oxo-11R,15S-dihydroxy-15-methyl-5Z,13E-prostadienoic acid, 15(S)-15-Methyl-pge2, 15(S)-15-Methyl-prostaglandin E2, 15(S)-15-Methylprostaglandin E2, 15(S)-15-methyl PGE2, orb1693990
Related forms of this compound
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-3-methyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid C21H34O5
Isomers (same molecular formula)
tetradecyl 3,4,5-trihydroxybenzoate C21H34O5
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3R)-3-hydroxy-3-methyloct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid C21H34O5
methyl (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate C21H34O5
methyl (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoate C21H34O5
2-hydroxy-1-[(3S,5R,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O5
2-hydroxy-1-[(3R,5R,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O5
(3R,5R,8S,9S,10S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-3,17-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O5
(3R,5R,8S,9S,10S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-3,17-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O5
2-hydroxy-1-[(3R,5S,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O5
methyl (5S,6E,8Z,10E,12E,14R,15S)-5,14,15-trihydroxyicosa-6,8,10,12-tetraenoate C21H34O5
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid C21H34O5